ReviewPublished 12 October 2026Chimeric antigen receptor-engineered cell therapy for asthma: advances in targeting type 2 inflammation and translational challengesYifei Niu · Chenyang Jian · Peize Liu · Mengwei Wu · Haoyuan Li · Xu Li · Lili ZhiFrontiers in Immunologydoi 10.3389/fimmu.2026.1979396
ReviewPublished 9 October 2026Microbiota–host crosstalk in ulcerative colitis: mechanistic evidence and translational prospects for traditional Chinese medicineJing Chen · Jing Du · Baoxi Mu · Jie Zhang · Guangbin Shang · Xiaojun YanFrontiers in Pharmacologydoi 10.3389/fphar.2026.1956353
CorrectionPublished 28 July 2026Correction: Fundamentals of dermatologic drug discoveryFrontiers Editorial OfficeFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1939675
ReviewPublished 10 July 2026Fundamentals of dermatologic drug discoveryAyman GradaFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1777138
Original ResearchPublished 9 July 2026Virtual screening and mechanistic elucidation of myricetin as a quorum sensing inhibitor targeting AhyI in Aeromonas hydrophilaBingxin Li · Qiyu Gu · Boqiang Wei · Hui Geng · Li XiongFrontiers in Aquaculturedoi 10.3389/faquc.2026.1815299
PerspectivePublished 4 May 2026Artificial intelligence for small-molecule chemical probe design: why drug-centric models may not transfer cleanlyRenzo Carlucci · Exequiel O. J. PortaFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1836983
